These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 9379505)

  • 21. Comprehensive analysis of p53 gene mutation characteristics in lung carcinoma with special reference to histological subtypes.
    Fujita T; Kiyama M; Tomizawa Y; Kohno T; Yokota J
    Int J Oncol; 1999 Nov; 15(5):927-34. PubMed ID: 10536175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of a mutation of the p21/WAF1 gene in human lung and pancreatic cancers.
    Shimizu T; Miwa W; Nakamori S; Ishikawa O; Konishi Y; Sekiya T
    Jpn J Cancer Res; 1996 Mar; 87(3):275-8. PubMed ID: 8613430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identical epidermal growth factor receptor mutations in adenocarcinomatous and squamous cell carcinomatous components of adenosquamous carcinoma of the lung.
    Kang SM; Kang HJ; Shin JH; Kim H; Shin DH; Kim SK; Kim JH; Chung KY; Kim SK; Chang J
    Cancer; 2007 Feb; 109(3):581-7. PubMed ID: 17186532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What causes p53 mutations in patients with lung cancer?
    Sekine I; Shao GG; Fahey M; Kodama T; Nagai K; Kuriyama T
    Oncol Rep; 1998; 5(5):1125-8. PubMed ID: 9683821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of EML4-ALK fusion genes in non-small cell lung cancer patients with clinical features associated with EGFR mutations.
    Shaozhang Z; Xiaomei L; Aiping Z; Jianbo H; Xiangqun S; Qitao Y
    Genes Chromosomes Cancer; 2012 Oct; 51(10):925-32. PubMed ID: 22736493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 alterations in plutonium-induced F344 rat lung tumors.
    Kelly G; Stegelmeier BL; Hahn FF
    Radiat Res; 1995 Jun; 142(3):263-9. PubMed ID: 7761575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relationship of epidermal growth factor receptor gene mutations, clinicopathologic features and prognosis in patients with non-small cell lung cancer].
    Fan MJ; Li HG; Lü ZQ; Zhang HZ; Shen XM
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):679-82. PubMed ID: 22321547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 immunostaining is correlated with reduced survival and is not correlated with gene mutations in resected pulmonary large cell carcinomas.
    Massoni Neto LM; Bianchi CP; Ab'Saber AM; Parra ER; Takagaki T; Pereira JC; Soares FA; Leite K; Capelozzi VL
    Braz J Med Biol Res; 2007 Aug; 40(8):1045-53. PubMed ID: 17665040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of p53 mutations between adenocarcinoma and squamous cell carcinoma of the lung: unique spectra involving G to A transitions and G to T transversions in both histologic types.
    Gao WM; Mady HH; Yu GY; Siegfried JM; Luketich JD; Melhem MF; Keohavong P
    Lung Cancer; 2003 May; 40(2):141-50. PubMed ID: 12711114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Epidermal growth factor receptor gene mutations and clinicopathologic correlation in 309 patients with non-small cell lung cancer].
    Feng Q; Li XH; Chen Z; He JS; Wang CX; Zhou LX; Xue WC
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):660-3. PubMed ID: 22321542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gender comparisons in human lung cancer: analysis of p53 mutations, anti-p53 serum antibodies and C-erbB-2 expression.
    Guinee DG; Travis WD; Trivers GE; De Benedetti VM; Cawley H; Welsh JA; Bennett WP; Jett J; Colby TV; Tazelaar H
    Carcinogenesis; 1995 May; 16(5):993-1002. PubMed ID: 7767998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Detection of epidermal growth factor receptor mutations in non-small-cell lung carcinoma by direct sequencing and correlations with clinicopathological characteristics and sample types].
    Sun MH; Yang F; Shen L; Zhang L; Chen Y; Cai X; Zhu XL; Zhou XY
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):655-9. PubMed ID: 22321541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene mutation analysis in non-small cell lung cancer patients using bronchoalveolar lavage fluid and tumor tissue as diagnostic markers.
    Li J; Hu YM; Wang Y; Tang XP; Shi WL; Du YJ
    Int J Biol Markers; 2014 Dec; 29(4):e328-36. PubMed ID: 24519547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53 gene aberrations in non-small-cell lung carcinomas from a smoking population.
    Liloglou T; Ross H; Prime W; Donnelly RJ; Spandidos DA; Gosney JR; Field JK
    Br J Cancer; 1997; 75(8):1119-24. PubMed ID: 9099958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer.
    Mitsudomi T; Oyama T; Kusano T; Osaki T; Nakanishi R; Shirakusa T
    J Natl Cancer Inst; 1993 Dec; 85(24):2018-23. PubMed ID: 8246288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus not found in squamous and large cell lung carcinomas by polymerase chain reaction.
    Fong KM; Schonrock J; Frazer IM; Zimmerman PV; Smith PJ
    Cancer; 1995 May; 75(9):2400-1. PubMed ID: 7712451
    [No Abstract]   [Full Text] [Related]  

  • 37. Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer.
    Ferretti G; Curigliano G; Pastorino U; Cittadini A; Flamini G; Calabrò MG; De Pas T; Orlando L; Mandalà M; Colleoni M; Spaggiari L; Granone PL; Pagliari G; de Braud F; Fazio N; Goldhirsch A
    Clin Cancer Res; 2000 Jun; 6(6):2393-400. PubMed ID: 10873091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [p53 gene abnormalities in advanced primary lung cancer and metastatic tumors].
    Taniguchi Y
    Nihon Ika Daigaku Zasshi; 1995 Jun; 62(3):241-50. PubMed ID: 7615696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent occurrence of p53 gene mutations in uterine cancers at advanced clinical stage and with aggressive histological phenotypes.
    Tsuda H; Hirohashi S
    Jpn J Cancer Res; 1992 Nov; 83(11):1184-91. PubMed ID: 1336492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carcinogen exposure, p53 alteration, and K-ras mutation in synchronous multiple primary lung carcinoma.
    Wang X; Christiani DC; Mark EJ; Nelson H; Wiencke JK; Gunn L; Wain JC; Kelsey KT
    Cancer; 1999 Apr; 85(8):1734-9. PubMed ID: 10223567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.